Precision Business Insights
Portfolio

 

Venous Leg Ulcer Treatment Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Venous Leg Ulcer Treatment Market: By Drug Class (Antibiotics, Corticosteroids, Monoclonal Antibodies, Immunosuppressant Drugs, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

 

 

Global Venous Leg Ulcer Treatment Market

 

Market Outline: Global Venous Leg Ulcer Treatment Market

Venous leg ulcer is a type of ulcer that occurs when the veins in legs failed to push the blood back to hear effectively. These are occur due to improper functioning of venous valves in the legs. Venous leg ulcers are common occurrence of chronic wounds, occurs in approximately 70% to 90% of leg ulcer cases. The symptoms associated with the venous leg ulcer include pain, swelling and itching in the leg, discoloration or hardening of skin around ulcer, and sore may produce a foul-smelling discharge.

 

Market Dynamics: Global Venous Leg Ulcer Treatment Market

Increase in the number of venous leg ulcer cases due to surge prevalence of neuropathic, metabolic, vascular disorders drives the global venous leg ulcer treatment market. Moreover, rise in R&D expenditure for the development of newer therapeutics to treat venous leg ulcer, promising pipeline products, grow in geriatric population, and rise in awareness about the venous leg ulcer treatment among the healthcare professionals are anticipated to surge the global venous leg ulcer treatment market over the forecast years. However, less number of existed drugs available in the market, high cost of treatment, poor disease awareness in underdeveloped countries, and adverse effects associated with the drugs are restrain the growth of global venous leg ulcer treatment market.

 

Market Scope: Global Venous Leg Ulcer Treatment Market

Global venous leg ulcer treatment market is segmented based on drug class, route of administration, and distribution channel

Based on drug class, market is segmented into the following:

  • Antibiotics
  • Corticosteroids
  • Monoclonal Antibodies
  • Immunosuppressant Drugs
  • Others

Geography

 North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Based on route of administration, market is segmented into the following:

  • Oral
  • Parenteral
  • Topical

Based on the distribution channel, market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Analysis: Global Venous Leg Ulcer Treatment Market

Geographically, global venous leg ulcer treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America venous leg ulcer treatment market is poised to grow due to rise in prevalence of venous leg ulcer cases in U.S and Canada, rise in R&D for the development of newer products, and favorable reimbursement policies are bolster the market. Europe venous leg ulcer treatment market is driving by increase in prevalence of lifestyle disorders such as obesity and diabetes, presence of huge number of market players, and early stage disease diagnosis in the Europe are surge the market. Asia Pacific venous leg ulcer treatment market has prominent share attributed to rise in disposable income, grow in awareness about the venous leg ulcer among healthcare professionals, and launch of newer products into the Asia Pacific region are fuel the market.

 

Competition Assessment: Global Venous Leg Ulcer Treatment Market

Some of the players in the global venous leg ulcer treatment market include:

  • Cardinal Health, Inc. (U.S.)
  • Genentech, Inc. (U.S.)
  • Hoffmann La Roche Ltd. (Switzerland)
  • Leap Therapeutics, Inc. (U.S.)
  • Daval International Ltd. (U.K.)
  • RegeneRx Biopharmaceuticals, Inc. (U.S.)
  • MediWound Ltd (Israel)
    
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials